You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

multi-agent chemotherapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial (Patritumab deruxtecan, Chemotherapy, Letrozole)

Recruiting
  • Breast Cancer
  • Patritumab deruxtecan
  • +2 more
  • Barcelona, Spain
    Hospital Clinic de Barcelona
Nov 28, 2022

Acute Lymphoblastic Leukemia Trial in Tampa (Hyper CVAD Protocol (Standard of Care Multi-Agent Chemotherapy), Calaspargase

Recruiting
  • Acute Lymphoblastic Leukemia
  • Hyper CVAD Protocol (Standard of Care Multi-Agent Chemotherapy)
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Oct 12, 2022

Acute,Leukemia, Lymphoid Trial in Tianjin (Dasatinib, prednisone, cyclophosphamide)

Completed
  • Acute,Leukemia, Lymphoid
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Aug 2, 2022

Pancreatic Cancer Trial in Baltimore (High Dose Rate Brachytherapy (HDR) Intraoperative Radiation Therapy (IORT))

Recruiting
  • Pancreatic Cancer
  • High Dose Rate Brachytherapy (HDR) Intraoperative Radiation Therapy (IORT)
  • Baltimore, Maryland
    Johns Hopkins Hospital
Jun 3, 2022

Breast Cancer Trial in Barcelona, Madrid, Valencia (Talimogene laherparepvec, Atezolizumab)

Active, not recruiting
  • Breast Cancer
  • Barcelona, Spain
  • +3 more
Sep 27, 2022

Metastatic Pancreatic Cancer Trial in Baltimore (Nab-paclitaxel, Gemcitabine, Cisplatin)

Recruiting
  • Metastatic Pancreatic Cancer
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Mar 14, 2022

ctDNA as a Biomarker for Treatment in Advanced NSCLC

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Fuzhou, Fujian, China
    900TH Hospital of Joint Logisti'cs Support Force
Aug 2, 2022

MDS, Acute Myeloid Leukemia Trial in France (BST-236)

Recruiting
  • Myelodysplastic Syndromes
  • Acute Myeloid Leukemia
  • Amiens, France
  • +16 more
Jan 2, 2023

Acute Myeloid Leukemia Trial in Cologne, Mainz, Munich (APX001 with Standard of Care anti-fungal agent)

Completed
  • Acute Myeloid Leukemia
  • APX001 with Standard of Care anti-fungal agent
  • Cologne, Germany
  • +2 more
Jun 6, 2022

Breast Cancer Trial in Spain (Ribociclib, Letrozole 2.5mg, Doxorubicin)

Completed
  • Breast Cancer
  • Barcelona, Spain
  • +20 more
Mar 16, 2021

AML, Adult, MDS, Relapse/Recurrence Trial in United States (BST-236)

Recruiting
  • AML, Adult
  • +3 more
  • Shreveport, Louisiana
  • +3 more
Jul 19, 2022

Metastatic Sarcoma Trial in Boston (PM01183, Doxorubicin, Gemcitabine)

Completed
Has Results
  • Metastatic Sarcoma
  • Boston, Massachusetts
  • +1 more
Feb 9, 2021

CD30 Positive Primary Mediastinal Large B-cell Lymphoma, CD30-Positive DLBCL, CD30-Positive Gray Zone Lymphoma Trial in

Completed
Has Results
  • CD30 Positive Primary Mediastinal Large B-cell Lymphoma
  • +2 more
  • brentuximab vedotin
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Dec 14, 2020

Chemotherapy Alone Versus Chemotherapy Plus Targeted Therapy as

Completed
  • Colorectal Cancer Metastatic
  • Targeted agent
  • (no location specified)
Aug 31, 2023

Triple Negative Breast Cancer, Neoadjuvant Chemo, Pembrolizumab Trial in Seoul (Visium, Whole Genome Sequencing(WGS)/Whole

Recruiting
  • Triple Negative Breast Cancer
  • +3 more
  • Visium, Whole Genome Sequencing(WGS)/Whole Transcriptome Sequencing(WTS)
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 15, 2023

Gadolinium-based Contrast Agent Reduction in Brain MRI (MAGNET)

Recruiting
  • Brain Diseases
  • Low-dose GBCA levels
  • Beijing, Beijing, China
    Beijing Tiantan Hospital
Mar 2, 2023

Lung Cancer, NSCLC Trial (Lorlatinib, Cisplatin or Carboplatin, Pemetrexed)

Not yet recruiting
  • Lung Cancer
  • Non-small Cell Lung Cancer
  • (no location specified)
Jul 7, 2023

Salivary Gland Cancer Trial (vedicitumomab (Edisil, RC48), vedicitumomab in combination with pyrrolizidine, RC48 in combination

Not yet recruiting
  • Salivary Gland Cancer
  • vedicitumomab (Edisil, RC48）
  • +3 more
  • (no location specified)
Jun 9, 2023

Pancreatic Cancer Trial in Dublin (Control, Intervention)

Not yet recruiting
  • Pancreatic Cancer
  • Control
  • Intervention
  • Dublin, Leinster, Ireland
    St Vincent's University Hospital
Nov 20, 2023

Rectal Cancer Trial (Trifluridine/Tipiracil, intensity-modulated radiotherapy)

Not yet recruiting
  • Rectal Cancer
  • (no location specified)
Jul 27, 2023

Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation Trial in Canton (TAS6417)

Recruiting
  • Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation
  • Canton, Ohio
    Gabrail Cancer and Research Center
Jul 25, 2023

Non-Squamous NSCLC (NSCLC), Adenocarcinoma of the Lung, Lung Cancer Trial in United States (Docetaxel, Nivolumab, Gemcitabine)

Terminated
Has Results
  • Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
  • +3 more
  • Anderson, Indiana
  • +8 more
Jul 7, 2022

Post Stroke Epilepsy Trial in Changsha (idebenone 30 mg for 14 days, idebenone 30 mg for 3 months)

Recruiting
  • Post Stroke Epilepsy
  • idebenone 30 mg for 14 days
  • idebenone 30 mg for 3 months
  • Changsha, Hunan, China
    Xiangya Hospital, Central South University
Aug 3, 2023

Cancer, Chemotherapeutic Agent Toxicity Trial in Santiago (Contigo Application)

Not yet recruiting
  • Cancer
  • Chemotherapeutic Agent Toxicity
  • Contigo Application
  • Santiago, Chile
    Complejo Asistencial Dr. Sotero del Río
Oct 10, 2023

Lung Cancer, Lung Metastases Trial in Orlando (VGT-309)

Recruiting
  • Lung Cancer
  • Lung Metastases
  • Orlando, Florida
    Orlando Health Cancer Institute
Nov 22, 2023